Author: PWeekly

Physician’s Weekly spoke recently with Roman Shinder, MD, FACS, from the Departments of Ophthalmology and Otolaryngology at SUNY Downstate Medical Center, about study results he and his colleague, Anna Artymowicz, MD, presented...

A genome-wide association study (GWAS) of dry eye (DE) suggests DE-associated single nucleotide polymorphisms (SNPs) are correlated with increased ocular pain and comorbidities, but not with DE signs, according to study...

Several significant advances have occurred in dry eye disease (DED) treatment in recent years, according to Amy Lin, MD. Including treatments with novel mechanisms of action and delivery systems. “This news is very exciting for...

The COVID-19 pandemic resulted in unforeseen changes in healthcare delivery for patients with MS, and the pandemic’s swift progression led to a knowledge gap about how the virus has impacted practice patterns for MS clinicians,...

In a dialysis-dependent population, patients with gout showed a higher cardiovascular comorbidity burden and an increased risk of hospitalization and mortality, compared with patients without gout. In addition, older age,...

Concomitant use of immunomodulators prolonged the effectiveness of pegloticase in patients with uncontrolled gout. Results from a large observational study were consistent with previously conducted smaller trials.1 The...

The effects of teprotumumab on volume of lacrimal glands and tear production were presented at ASOPRS 2021. Dry eye syndrome is a common cause of discomfort among individuals with thyroid eye disease and can occur in up to 85%...

When virtual schooling became the new norm during the COVID-19 pandemic, ophthalmologists predicted an increase in digital eye strain in children. Study results have confirmed that the increased screen time did lead to more eye...

In a randomized, triple-blind, phase II clinical trial, investigators sought to determine the effectiveness of a subconjunctival novel sirolimus liposomal formulation for treating dry eye. The study, which included 19 patients...

New treatments are needed to improve the signs and symptoms of dry eye, according to researchers who conducted the ONSET-2 phase III trial, which randomized 758 subjects 1:1:1 to placebo, 0.6 mg/mL OC-01 (Varenicline) nasal...